Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Lancet Neurol

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    April 2017
  1. VOSSEL KA, Tartaglia MC, Nygaard HB, Zeman AZ, et al
    Epileptic activity in Alzheimer's disease: causes and clinical relevance.
    Lancet Neurol. 2017;16:311-322.
    PubMed     Text format     Abstract available


    February 2017
  2. THE LANCET NEUROLOGY
    Solanezumab: too late in mild Alzheimer's disease?
    Lancet Neurol. 2017;16:97.
    PubMed     Text format    


    January 2017
  3. SCHNEIDER L
    Alzheimer's disease and other dementias: update on research.
    Lancet Neurol. 2017;16:4-5.
    PubMed     Text format    


  4. ATTEMS J
    Alzheimer's disease pathology in synucleinopathies.
    Lancet Neurol. 2017;16:22-23.
    PubMed     Text format    


    December 2016
  5. PANZA F, Logroscino G
    Anti-tau vaccine in Alzheimer's disease: a tentative step.
    Lancet Neurol. 2016 Dec 9. pii: S1474-4422(16)30340.
    PubMed     Text format    


  6. NOVAK P, Schmidt R, Kontsekova E, Zilka N, et al
    Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Lancet Neurol. 2016 Dec 9. pii: S1474-4422(16)30331.
    PubMed     Text format     Abstract available


    October 2016
  7. RYAN NS, Nicholas JM, Weston PS, Liang Y, et al
    Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30193.
    PubMed     Text format     Abstract available


  8. VAN DER FLIER WM
    Clinical heterogeneity in familial Alzheimer's disease.
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30275.
    PubMed     Text format    


  9. TANG M, Ryman DC, McDade E, Jasielec MS, et al
    Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30229.
    PubMed     Text format     Abstract available


    July 2016
  10. BISCHOF GN
    Alzheimer's disease risk: amyloid versus neurodegeneration.
    Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30138.
    PubMed     Text format    


  11. BURNHAM SC, Bourgeat P, Dore V, Savage G, et al
    Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30125.
    PubMed     Text format     Abstract available


  12. MORGAN J
    Early onset Alzheimer's disease: many mountains to climb.
    Lancet Neurol. 2016;15:798.
    PubMed     Text format    


  13. CUYVERS E, Sleegers K
    Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond.
    Lancet Neurol. 2016;15:857-68.
    PubMed     Text format     Abstract available


    June 2016
  14. NELSON PT
    Cerebrovascular pathology and Alzheimer's disease.
    Lancet Neurol. 2016 Jun 13. pii: S1474-4422(16)30038.
    PubMed     Text format    


  15. ARVANITAKIS Z, Capuano AW, Leurgans SE, Bennett DA, et al
    Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.
    Lancet Neurol. 2016 Jun 13. pii: S1474-4422(16)30029.
    PubMed     Text format     Abstract available


  16. MORGAN J
    "A big decision": living with early onset familial Alzheimer's disease.
    Lancet Neurol. 2016;15:671.
    PubMed     Text format    


  17. TARIOT PN, Langbaum JB, Reiman EM
    What are we willing to accept for preventing Alzheimer's disease? - Investigators' reply.
    Lancet Neurol. 2016;15:660-1.
    PubMed     Text format    


  18. CESARI M, Vanacore N, Canevelli M
    What are we willing to accept for preventing Alzheimer's disease?
    Lancet Neurol. 2016;15:659-60.
    PubMed     Text format    


  19. FRISONI GB, Hansson O
    Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?
    Lancet Neurol. 2016;15:650-1.
    PubMed     Text format    


  20. THE LANCET NEUROLOGY
    Finding a cure for Alzheimer's disease starts with prevention.
    Lancet Neurol. 2016;15:649.
    PubMed     Text format    


    April 2016
  21. OLSSON B, Lautner R, Andreasson U, Ohrfelt A, et al
    CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
    Lancet Neurol. 2016 Apr 8. pii: S1474-4422(16)00070.
    PubMed     Text format     Abstract available


  22. WINBLAD B, Amouyel P, Andrieu S, Ballard C, et al
    Defeating Alzheimer's disease and other dementias: a priority for European science and society.
    Lancet Neurol. 2016;15:455-532.
    PubMed     Text format    


  23. MAZURE CM, Swendsen J
    Sex differences in Alzheimer's disease and other dementias.
    Lancet Neurol. 2016;15:451-2.
    PubMed     Text format    


  24. QUAGLIO G, Brand H, Dario C
    Fighting dementia in Europe: the time to act is now.
    Lancet Neurol. 2016;15:452-4.
    PubMed     Text format    


    December 2015
  25. WRAY S, Fox NC
    Stem cell therapy for Alzheimer's disease: hope or hype?
    Lancet Neurol. 2015 Dec 15. pii: S1474-4422(15)00382.
    PubMed     Text format    


  26. HUNSBERGER JG, Rao M, Kurtzberg J, Bulte JW, et al
    Accelerating stem cell trials for Alzheimer's disease.
    Lancet Neurol. 2015 Dec 15. pii: S1474-4422(15)00332.
    PubMed     Text format     Abstract available


    November 2015
  27. VOS SJ, Fagan AM
    Alzheimer's disease biomarker states.
    Lancet Neurol. 2015 Nov 17. pii: S1474-4422(15)00335.
    PubMed     Text format    


    October 2015
  28. HOWARD R, McShane R, Lindesay J, Ritchie C, et al
    Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.
    Lancet Neurol. 2015 Oct 26. pii: S1474-4422(15)00258.
    PubMed     Text format     Abstract available


  29. WIMO A
    Long-term effects of Alzheimer's disease treatment.
    Lancet Neurol. 2015 Oct 26. pii: S1474-4422(15)00302.
    PubMed     Text format    


    September 2015
  30. LAUNER LJ
    Preventing Alzheimer's disease is difficult.
    Lancet Neurol. 2015;14:872-4.
    PubMed     Text format    


    August 2015
  31. TEIPEL S, Drzezga A, Grothe MJ, Barthel H, et al
    Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.
    Lancet Neurol. 2015 Aug 26. pii: S1474-4422(15)00093.
    PubMed     Text format     Abstract available


  32. GROSSMAN M
    Integrated multimodal imaging in neurodegenerative disease.
    Lancet Neurol. 2015 Aug 26. pii: S1474-4422(15)00182.
    PubMed     Text format    


  33. KIRBY T
    William Klunk: imaging Alzheimer's disease in vivo.
    Lancet Neurol. 2015;14:791.
    PubMed     Text format    


  34. THE LANCET NEUROLOGY
    Alzheimer's disease: a time for cautious optimism.
    Lancet Neurol. 2015;14:779.
    PubMed     Text format    


    July 2015
  35. ANDRIEU S, Coley N, Lovestone S, Aisen PS, et al
    Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions.
    Lancet Neurol. 2015 Jul 23. pii: S1474-4422(15)00153.
    PubMed     Text format     Abstract available


  36. BIANCHI A
    Sir Terry Pratchett: shaking hands with Death.
    Lancet Neurol. 2015;14:691.
    PubMed     Text format    


    June 2015
  37. FARRER LA
    Expanding the genomic roadmap of Alzheimer's disease.
    Lancet Neurol. 2015 Jun 30. pii: S1474-4422(15)00146.
    PubMed     Text format    


  38. CUYVERS E, De Roeck A, Van den Bossche T, Van Cauwenberghe C, et al
    Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Lancet Neurol. 2015 Jun 30. pii: S1474-4422(15)00133.
    PubMed     Text format     Abstract available


  39. FRISONI GB, Visser PJ
    Biomarkers for Alzheimer's disease: a controversial topic.
    Lancet Neurol. 2015 Jun 29. pii: S1474-4422(15)00150.
    PubMed     Text format    


  40. YAU WW, Tudorascu DL, McDade EM, Ikonomovic S, et al
    Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Lancet Neurol. 2015 Jun 29. pii: S1474-4422(15)00135.
    PubMed     Text format     Abstract available


    May 2015
  41. HOLMES D
    Stuart Lipton: UFOs and flying tigers.
    Lancet Neurol. 2015;14:464.
    PubMed     Text format    


    April 2015
  42. HENEKA MT, Carson MJ, Khoury JE, Landreth GE, et al
    Neuroinflammation in Alzheimer's disease.
    Lancet Neurol. 2015;14:388-405.
    PubMed     Text format     Abstract available


    January 2015
  43. BATEMAN R
    Alzheimer's disease and other dementias: advances in 2014.
    Lancet Neurol. 2015;14:4-6.
    PubMed     Text format    


    December 2014
  44. THE LANCET NEUROLOGY
    Raising standards in dementia care.
    Lancet Neurol. 2014;13:1161.
    PubMed     Text format    


    October 2014
  45. HOLMES D
    Clifford Jack: biomarker curves and all that jazz.
    Lancet Neurol. 2014;13:973.
    PubMed     Text format    


  46. JACK CR JR, Wiste HJ, Weigand SD, Rocca WA, et al
    Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.
    Lancet Neurol. 2014;13:997-1005.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: